When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Adrenal suppression

Última revisão: 13 Feb 2025
Última atualização: 12 Apr 2022

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • presence of risk factors
  • sudden cessation or rapid tapering of glucocorticoids
  • acute circulatory collapse with hypotension and tachycardia
Detalhes completos

Outros fatores diagnósticos

  • lassitude and generalized constitutional symptoms
  • history of weight gain and increased appetite
  • history of depression, agitation, or sleep disorders
  • cushingoid exam features
  • history of difficult-to-control diabetes or hypertension
  • absence of hyperpigmentation or autoimmune stigmata
  • medroxyprogesterone use
  • history of treatment for endogenous Cushing syndrome
Detalhes completos

Fatores de risco

  • systemic glucocorticoid administration
  • high potency or dose of exogenous glucocorticoids
  • prolonged glucocorticoid treatment (e.g., >3 weeks)
  • local glucocorticoid administration
  • megestrol use
  • nonphysiologic scheduling of glucocorticoid dose
  • medroxyprogesterone use
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • serum comprehensive chemistry panel
  • serum a.m. cortisol
  • salivary a.m. cortisol
  • adrenocorticotropic hormone (ACTH) stimulation test
  • CBC
  • thyroid function tests
Detalhes completos

Investigações a serem consideradas

  • insulin tolerance test (ITT)
  • overnight metyrapone test
  • urine synthetic glucocorticoids
Detalhes completos

Algoritmo de tratamento

Inicial

features of adrenal crisis

AGUDA

minor intercurrent stress

severe intercurrent stress

CONTÍNUA

stable patients taking corticosteroids for underlying disease: suitable for discontinuation or taper

Colaboradores

Autores

Suzanne L. Quinn Martinez, MD
Suzanne L. Quinn Martinez

Staff Endocrinologist

Orlando Veterans Administration Hospital

Associate Professor Internal Medicine

University of Central Florida

Orlando

FL

Declarações

SLQM declares that she has no competing interests.

Agradecimentos

Dr Suzanne L. Quinn Martinez would like to gratefully acknowledge Dr M. Cecilia Lansang, a previous contributor to this topic.

Declarações

MCL is a consultant for the Sanofi group of companies and is an author of several references cited in this topic.

Revisores

Diane Mary Donegan, MB BCh BAO, MRCPI, Ms

Assistant Professor of Medicine

Indiana University

Indianapolis

MI

Declarações

DMD is a member of a paid advisory board for Recordati and Corcept. DMD is also a site investigator for Corcept and Chiasma.

Antoine Tabarin, MD

Head

Department of Endocrinology

University Hospital of Bordeaux

Pessac

France

Declarações

AT declares that he has no competing interests.

Maralyn Druce, MA, MBBS, MRCP, PhD

Clinical Lecturer

Honorary Consultant

Department of Endocrinology

Barts and The London School of Medicine and Dentistry

St Bartholomew's Hospital

London

UK

Declarações

MD declares that she has no competing interests.

  • Diagnósticos diferenciais

    • Primary adrenal insufficiency
    • Pituitary compression, tumor, head trauma, and surgery (non-Cushing)
    • Corticosteroid withdrawal syndrome
    Mais Diagnósticos diferenciais
  • Diretrizes

    • Adrenal suppression from exogenous glucocorticoids: recognizing risk factors and preventing morbidity
    • Emergency management of acute adrenal insufficiency (adrenal crisis) in adult patients
    Mais Diretrizes
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal